FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200156913> ?p ?o ?g. }

• W4200156913 endingPage "105" @default.
• W4200156913 startingPage "96" @default.
• W4200156913 abstract "In August, 2015, the UK implemented an emergency adolescent immunisation programme with the meningococcal ACWY conjugate vaccine to combat a national outbreak of meningococcal group W (MenW) disease due to a hypervirulent ST-11 complex strain, which is currently causing regional and national outbreaks worldwide. This immunisation programme specifically targeted adolescents aged 13-18 years, an age group with low disease incidence but high nasopharyngeal carriage, with the aim of interrupting transmission and providing indirect (herd) protection across the population. Here, we report the impact of the first 4 years of the programme in England.Public Health England conducts meningococcal disease surveillance in England. Laboratory-confirmed cases of invasive meningococcal disease during the academic years 2010-11 to 2014-15 (Sept 1 to Aug 31) were used to predict post-vaccination trends, based on the assumption that cases would plateau 1 year after vaccine implementation (conservative scenario) or that cases would continue to rise for 4 years after vaccine implementation (extreme scenario). Vaccine uptake evaluated in August, 2019, was 37-41% in adolescents aged 18 years immunised in primary care and 71-86% in younger teenagers routinely vaccinated in school. Vaccine effectiveness was estimated with the indirect screening method.MenW and MenY cases plateaued within 12 months and then declined, while MenC cases remained low throughout. Significant reductions were observed among adolescents aged 14-18 years for MenW (incidence rate ratio [IRR] 0·35 [95% CI 0·17-0·76]) and MenY (0·21 [0·07-0·59]) cases, with a non-significant reduction in MenC cases (0·11 [0·01-1·01]). Based on conservative and extreme scenarios, 205-1193 MenW cases were prevented through the indirect effects of the programme and 25 through direct protection. For MenY, an estimated 60-106 cases were prevented through the indirect effects of the programme and 19 through direct protection. Ignoring any residual effect from an earlier MenC-containing vaccine, the overall vaccine effectiveness against MenCWY disease combined was 94% (95% CI 80-99).A meningococcal immunisation programme specifically targeting adolescent carriers succeeded in rapidly controlling a national MenW outbreak, even with moderate initial vaccine uptake.Public Health England." @default.
• W4200156913 created "2021-12-31" @default.
• W4200156913 creator A5046888535 @default.
• W4200156913 creator A5047481687 @default.
• W4200156913 creator A5050597590 @default.
• W4200156913 creator A5053121427 @default.
• W4200156913 creator A5057251622 @default.
• W4200156913 creator A5059188706 @default.
• W4200156913 creator A5065434292 @default.
• W4200156913 creator A5068497518 @default.
• W4200156913 creator A5072485453 @default.
• W4200156913 creator A5076485991 @default.
• W4200156913 date "2022-02-01" @default.
• W4200156913 modified "2023-10-15" @default.
• W4200156913 title "Impact of an adolescent meningococcal ACWY immunisation programme to control a national outbreak of group W meningococcal disease in England: a national surveillance and modelling study" @default.
• W4200156913 cites W1030938068 @default.
• W4200156913 cites W1988495261 @default.
• W4200156913 cites W2004976172 @default.
• W4200156913 cites W2013735067 @default.
• W4200156913 cites W2025502898 @default.
• W4200156913 cites W2080750546 @default.
• W4200156913 cites W2093931806 @default.
• W4200156913 cites W2125575751 @default.
• W4200156913 cites W2137586712 @default.
• W4200156913 cites W2142373856 @default.
• W4200156913 cites W2143416879 @default.
• W4200156913 cites W2188361215 @default.
• W4200156913 cites W2197703503 @default.
• W4200156913 cites W2333931986 @default.
• W4200156913 cites W2342242813 @default.
• W4200156913 cites W2464861930 @default.
• W4200156913 cites W2554542903 @default.
• W4200156913 cites W2555725337 @default.
• W4200156913 cites W2576775543 @default.
• W4200156913 cites W2602921194 @default.
• W4200156913 cites W2606665334 @default.
• W4200156913 cites W2748398359 @default.
• W4200156913 cites W2755223435 @default.
• W4200156913 cites W2770647096 @default.
• W4200156913 cites W2800778923 @default.
• W4200156913 cites W2810428138 @default.
• W4200156913 cites W2895883063 @default.
• W4200156913 cites W2907358602 @default.
• W4200156913 cites W2952445679 @default.
• W4200156913 cites W2997269119 @default.
• W4200156913 cites W3124733160 @default.
• W4200156913 cites W3137952195 @default.
• W4200156913 cites W3164937600 @default.
• W4200156913 cites W3177489937 @default.
• W4200156913 doi "https://doi.org/10.1016/s2352-4642(21)00335-7" @default.
• W4200156913 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34883094" @default.
• W4200156913 hasPublicationYear "2022" @default.
• W4200156913 type Work @default.
• W4200156913 citedByCount "11" @default.
• W4200156913 countsByYear W42001569132021 @default.
• W4200156913 countsByYear W42001569132022 @default.
• W4200156913 countsByYear W42001569132023 @default.
• W4200156913 crossrefType "journal-article" @default.
• W4200156913 hasAuthorship W4200156913A5046888535 @default.
• W4200156913 hasAuthorship W4200156913A5047481687 @default.
• W4200156913 hasAuthorship W4200156913A5050597590 @default.
• W4200156913 hasAuthorship W4200156913A5053121427 @default.
• W4200156913 hasAuthorship W4200156913A5057251622 @default.
• W4200156913 hasAuthorship W4200156913A5059188706 @default.
• W4200156913 hasAuthorship W4200156913A5065434292 @default.
• W4200156913 hasAuthorship W4200156913A5068497518 @default.
• W4200156913 hasAuthorship W4200156913A5072485453 @default.
• W4200156913 hasAuthorship W4200156913A5076485991 @default.
• W4200156913 hasConcept C106192422 @default.
• W4200156913 hasConcept C107130276 @default.
• W4200156913 hasConcept C116675565 @default.
• W4200156913 hasConcept C120665830 @default.
• W4200156913 hasConcept C121332964 @default.
• W4200156913 hasConcept C126322002 @default.
• W4200156913 hasConcept C138816342 @default.
• W4200156913 hasConcept C142724271 @default.
• W4200156913 hasConcept C144024400 @default.
• W4200156913 hasConcept C147483822 @default.
• W4200156913 hasConcept C149923435 @default.
• W4200156913 hasConcept C159047783 @default.
• W4200156913 hasConcept C159110408 @default.
• W4200156913 hasConcept C187212893 @default.
• W4200156913 hasConcept C203014093 @default.
• W4200156913 hasConcept C22070199 @default.
• W4200156913 hasConcept C2776645655 @default.
• W4200156913 hasConcept C2778458888 @default.
• W4200156913 hasConcept C2779134260 @default.
• W4200156913 hasConcept C2780454893 @default.
• W4200156913 hasConcept C2780801004 @default.
• W4200156913 hasConcept C2908647359 @default.
• W4200156913 hasConcept C3008058167 @default.
• W4200156913 hasConcept C32762888 @default.
• W4200156913 hasConcept C37701844 @default.
• W4200156913 hasConcept C523546767 @default.
• W4200156913 hasConcept C524204448 @default.
• W4200156913 hasConcept C54355233 @default.
• W4200156913 hasConcept C61511704 @default.
• W4200156913 hasConcept C71924100 @default.

• next